Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Cash & Equivalents (2016 - 2025)

Balchem (BCPC) has disclosed Cash & Equivalents for 16 consecutive years, with $74.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 50.6% to $74.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $74.6 million, a 50.6% increase, with the full-year FY2025 number at $74.6 million, up 50.6% from a year prior.
  • Cash & Equivalents was $74.6 million for Q4 2025 at Balchem, up from $65.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $103.2 million in Q4 2021 to a low of $49.5 million in Q4 2024.
  • A 5-year average of $69.8 million and a median of $66.0 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 37.24% in 2022, then soared 50.6% in 2025.
  • Balchem's Cash & Equivalents stood at $103.2 million in 2021, then tumbled by 35.53% to $66.6 million in 2022, then dropped by 3.17% to $64.4 million in 2023, then fell by 23.17% to $49.5 million in 2024, then skyrocketed by 50.6% to $74.6 million in 2025.
  • Per Business Quant, the three most recent readings for BCPC's Cash & Equivalents are $74.6 million (Q4 2025), $65.1 million (Q3 2025), and $65.4 million (Q2 2025).